Home›People›Marc Salzberg
Marc Salzberg

Marc Salzberg

Chairman & Chief Executive Officer at Airway Therapeutics.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Sep 9, 2026·Suggest an edit

About Marc Salzberg

Marc Salzberg is a chairman & chief executive officer at Airway Therapeutics.

Marc Salzberg first appears on SEC filings in 2018.

Experience

This experience comes from Marc Salzberg's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marc Salzberg in the role, so the role may have started earlier or lasted longer.

Airway Therapeutics, Inc. Current
Chairman & Chief Executive Officer
Chairman, Chief Executive & Medical Officer (2013 – Present)
2013 – Present · Marietta, GA
Develops experimental therapies for preterm infants and others with respiratory and inflammatory diseases.
Denothex Ltd.
Chairman
2015 – 2019
Medpace
Vice President Medical Affairs
2009 – 2013
Pharma Brains Ltd.
President & CEO
2000 – 2009
Clinical Cancer Research Center Switzerland (CCRC)
Director CCRC
2000 – 2005
University Hospital Basel
Director Clinical Cancer Research
1999 – 2005
Hoffmann-La Roche
International Medical Manager Oncology
1994 – 1999

Key Colleagues at Startups

The people Marc Salzberg works with at each company, as listed on that company's latest Form D.

Airway Therapeutics, Inc. · Form D, Sep 9, 2026
DL
Doug Loftus
Director
Alan Wolk
Alan Wolk
Chief Financial Officer & Chief Operating Officer, director
JT
Joe Todicsco
Director

Sources

  1. SECAirway Therapeutics, Inc. Form D, filed Sep 9, 2026